Comparative Bioavailability Clinical Trial
Official title:
A Marketing-oriented Study to Evaluate the Comparative Bioavailability of Omega-3 Fatty Acids From Four Different Natural Health Products
Supplementation with omega-3 fatty acids has been extensively researched and is known to
provide healthful benefits for patients with a diversity of conditions and diseases. Not all
omega-3 supplements are created equally however; some sources of omega-3 fatty acids are
superior to others due to a greater bioavailability of omega-3 fatty acids than others,
differences in source material, and processing techniques.
The purpose of this study is to determine which marketed omega-3 product provided the
greatest effect, as measured against its' label claim and recommended dosage.
n/a
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04790136 -
Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration
|
Phase 1 | |
| Withdrawn |
NCT02980757 -
Bioequivalence Study of Gliclazide 120 mg Modified Release Tablets
|
Phase 1 | |
| Completed |
NCT04505787 -
S-flurbiprofen Bioavailability Trial to Compare a Newly Developed Patch vs. a Marketed Tablet
|
Phase 1 | |
| Withdrawn |
NCT02217670 -
Comparative Bioavailability Study of Metformin HCl 1000 mg Granules vs Glucophage 1000 mg Film-coated Tablet
|
Phase 1 |